Advertisement
BCRX or BMRN or PTCT
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BCRX’s FA Score shows that 1 FA rating(s) are green whileBMRN’s FA Score has 0 green FA rating(s), and PTCT’s FA Score reflects 1 green FA rating(s).
- BCRX’s FA Score: 1 green, 4 red.
- BMRN’s FA Score: 0 green, 5 red.
- PTCT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BCRX’s TA Score shows that 4 TA indicator(s) are bullish while BMRN’s TA Score has 3 bullish TA indicator(s), and PTCT’s TA Score reflects 3 bullish TA indicator(s).
- BCRX’s TA Score: 4 bullish, 5 bearish.
- BMRN’s TA Score: 3 bullish, 7 bearish.
- PTCT’s TA Score: 3 bullish, 6 bearish.
Price Growth
BCRX (@Biotechnology) experienced а -1.71% price change this week, while BMRN (@Biotechnology) price change was -1.39% , and PTCT (@Biotechnology) price fluctuated -1.89% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.
Reported Earning Dates
BCRX is expected to report earnings on Oct 29, 2025.
BMRN is expected to report earnings on Oct 22, 2025.
PTCT is expected to report earnings on Oct 23, 2025.
Industries' Descriptions
@Biotechnology (+2.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| BCRX | BMRN | PTCT | |
| Capitalization | 1.8B | 11B | 3.78B |
| EBITDA | 47.6M | 777M | 839M |
| Gain YTD | 14.495 | -12.840 | 7.510 |
| P/E Ratio | N/A | 21.22 | 7.32 |
| Revenue | 503M | 2.95B | 1.77B |
| Total Cash | 295M | 1.27B | 2.03B |
| Total Debt | 795M | 602M | 390M |
BCRX | BMRN | PTCT | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 13 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | 62 Fair valued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 75 | 100 | 100 | |
SMR RATING 1..100 | 100 | 70 | 100 | |
PRICE GROWTH RATING 1..100 | 54 | 62 | 52 | |
P/E GROWTH RATING 1..100 | 100 | 99 | 21 | |
SEASONALITY SCORE 1..100 | 50 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BCRX's Valuation (33) in the Biotechnology industry is in the same range as BMRN (62) and is significantly better than the same rating for PTCT (99). This means that BCRX's stock grew similarly to BMRN’s and significantly faster than PTCT’s over the last 12 months.
BCRX's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as BMRN (100) and is in the same range as PTCT (100). This means that BCRX's stock grew similarly to BMRN’s and similarly to PTCT’s over the last 12 months.
BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as BCRX (100) and is in the same range as PTCT (100). This means that BMRN's stock grew similarly to BCRX’s and similarly to PTCT’s over the last 12 months.
PTCT's Price Growth Rating (52) in the Biotechnology industry is in the same range as BCRX (54) and is in the same range as BMRN (62). This means that PTCT's stock grew similarly to BCRX’s and similarly to BMRN’s over the last 12 months.
PTCT's P/E Growth Rating (21) in the Biotechnology industry is significantly better than the same rating for BMRN (99) and is significantly better than the same rating for BCRX (100). This means that PTCT's stock grew significantly faster than BMRN’s and significantly faster than BCRX’s over the last 12 months.
| BCRX | BMRN | PTCT | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 69% | N/A |
| Stochastic ODDS (%) | 4 days ago 85% | 2 days ago 72% | 2 days ago 78% |
| Momentum ODDS (%) | 4 days ago 86% | 2 days ago 72% | 2 days ago 85% |
| MACD ODDS (%) | N/A | 2 days ago 61% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 66% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 52% | 2 days ago 75% |
| Advances ODDS (%) | 11 days ago 79% | 11 days ago 58% | 3 days ago 75% |
| Declines ODDS (%) | 4 days ago 79% | 2 days ago 63% | 12 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 61% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 58% | 2 days ago 67% |
Advertisement
BCRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To BCRX | 1D Price Change % | ||
|---|---|---|---|---|
| BCRX | 100% | -1.03% | ||
| VCYT - BCRX | 46% Loosely correlated | -2.93% | ||
| CRNX - BCRX | 41% Loosely correlated | -5.78% | ||
| ETNB - BCRX | 39% Loosely correlated | -1.50% | ||
| BEAM - BCRX | 39% Loosely correlated | +1.47% | ||
| ROIV - BCRX | 39% Loosely correlated | -1.80% | ||
More | ||||
BMRN and
Correlation & Price change
A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.
| Ticker / NAME | Correlation To BMRN | 1D Price Change % | ||
|---|---|---|---|---|
| BMRN | 100% | -1.85% | ||
| ITOS - BMRN | 50% Loosely correlated | N/A | ||
| SRPT - BMRN | 45% Loosely correlated | -35.94% | ||
| IONS - BMRN | 43% Loosely correlated | -0.97% | ||
| IBO - BMRN | 42% Loosely correlated | -7.45% | ||
| AXON - BMRN | 42% Loosely correlated | +1.37% | ||
More | ||||